Institute of Cancer Sciences
The Institute of Cancer Sciences is part of the College of Medical, Veterinary and Life Sciences
The Institute of Cancer Sciences is part of a national centre of excellence in the fight against cancer. We carry out a programme of world-class science directed at understanding the molecular changes that cause cancer. We are working to translate scientific discoveries into new drugs or diagnostic and prognostic tools that benefit cancer patients, taking new therapies through preclinical and clinical trials. The Institute of Cancer Sciences is a major component of the Cancer Research UK West of Scotland Cancer Centre.
The Institute is a partner with the Beatson Institute for Cancer Research (BICR), which together form the core of cancer research in Glasgow. Together, there are currently 38 research groups housed in magnificent new research buildings at the Beatson Institute for Cancer Research, the Paul O’Gorman Leukaemia Research Centre and the CRUK clinical trials unit (CTU). The Translational Research Centre, due to open in 2012, will provide excellent facilities for an expanded programme of translational cancer research in Glasgow. Our facilities house a number of state-of-the-art technologies that underpin our key research themes. We provide outstanding training opportunities for young scientists and host many seminars and meetings to bring all the news from the international cancer research community to Glasgow.
Faculty Positions in the Institute of Cancer Sciences
The Institute of Cancer Sciences is undergoing a strategic expansion, in partnership with the Beatson Institute for Cancer Research that includes the completion of a new research complex providing space for 400 research staff. We offer an outstanding environment for our scientists with state-of-the-art facilities. The Institute of Cancer Sciences at the University of Glasgow invites applications from successful and highly motivated scientists to develop and lead an independent programme of world-class research focused on understanding cancer development and progression, and translational aspects of these studies. Futher details.